Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Spectral Med Inc

EDT
Current price
0.56 CAD 0 CAD (0.00%)
Last closed 0.57 CAD
ISIN CA8475771033
Sector Healthcare
Industry Diagnostics & Research
Exchange Toronto Exchange
Capitalization 159 999 628 CAD
Yield for 12 month +64.71 %
1Y
3Y
5Y
10Y
15Y
EDT
21.11.2021 - 28.11.2021

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. Address: 135 The West Mall, Toronto, ON, Canada, M9C 1C2

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.81 CAD

P/E ratio

Dividend Yield

Current Year

+1 614 378 CAD

Last Year

+1 684 086 CAD

Current Quarter

+475 827 CAD

Last Quarter

+674 846 CAD

Current Year

-4 860 308 CAD

Last Year

+993 075 CAD

Current Quarter

-2 105 360 CAD

Last Quarter

-928 419 CAD

Key Figures EDT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 248 262 CAD
Operating Margin TTM -946.07 %
PE Ratio
Return On Assets TTM -93.22 %
PEG Ratio
Return On Equity TTM -973.97 %
Wall Street Target Price 2.81 CAD
Revenue TTM 1 920 484 CAD
Book Value -0.06 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 53.9 %
Dividend Yield
Gross Profit TTM 993 075 CAD
Earnings per share -0.071 CAD
Diluted Eps TTM -0.071 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EDT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EDT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 19.12.2011
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EDT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 86.2138
Price Sales TTM 83.3122
Enterprise Value EBITDA -7.5083
Price Book MRQ 49.8661

Financials EDT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EDT

For 52 weeks

0.33 CAD 0.76 CAD
50 Day MA 0.62 CAD
Shares Short Prior Month 864 161
200 Day MA 0.55 CAD
Short Ratio 1.04
Shares Short 95 221
Short Percent 0.13 %